vs
Side-by-side financial comparison of Bluerock Homes Trust, Inc. (BHM) and FENNEC PHARMACEUTICALS INC. (FENC). Click either name above to swap in a different company.
Bluerock Homes Trust, Inc. is the larger business by last-quarter revenue ($18.9M vs $13.8M, roughly 1.4× FENNEC PHARMACEUTICALS INC.). FENNEC PHARMACEUTICALS INC. runs the higher net margin — -34.7% vs -50.1%, a 15.4% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 35.9%). Over the past eight quarters, Bluerock Homes Trust, Inc.'s revenue compounded faster (30.1% CAGR vs -26.3%).
Bluerock Homes Trust, Inc. is a U.S.-headquartered real estate investment trust that acquires, owns and operates a portfolio of high-quality single-family rental residential properties. It caters to middle-market renters across high-growth suburban markets, prioritizing regions with strong demographic fundamentals and sustained rental housing demand.
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
BHM vs FENC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.9M | $13.8M |
| Net Profit | $-9.5M | $-4.8M |
| Gross Margin | — | — |
| Operating Margin | -48.8% | -18.5% |
| Net Margin | -50.1% | -34.7% |
| Revenue YoY | 35.9% | 73.8% |
| Net Profit YoY | -29.9% | -141.1% |
| EPS (diluted) | $-0.75 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.9M | $13.8M | ||
| Q3 25 | $16.6M | $12.5M | ||
| Q2 25 | $16.8M | $9.7M | ||
| Q1 25 | $16.4M | $8.8M | ||
| Q4 24 | $13.9M | $7.9M | ||
| Q3 24 | $12.7M | $7.0M | ||
| Q2 24 | $12.5M | $7.3M | ||
| Q1 24 | $11.2M | $25.4M |
| Q4 25 | $-9.5M | $-4.8M | ||
| Q3 25 | $-10.0M | $-638.0K | ||
| Q2 25 | $-5.8M | $-3.2M | ||
| Q1 25 | $-7.3M | $-1.2M | ||
| Q4 24 | $-7.3M | $-2.0M | ||
| Q3 24 | $3.5M | $-5.7M | ||
| Q2 24 | $-5.2M | $-5.6M | ||
| Q1 24 | $-3.2M | $12.8M |
| Q4 25 | -48.8% | -18.5% | ||
| Q3 25 | -57.6% | -1.5% | ||
| Q2 25 | -30.9% | -28.3% | ||
| Q1 25 | -42.6% | -9.2% | ||
| Q4 24 | -52.8% | -11.8% | ||
| Q3 24 | 27.9% | -74.6% | ||
| Q2 24 | -41.3% | -69.4% | ||
| Q1 24 | -28.4% | 54.2% |
| Q4 25 | -50.1% | -34.7% | ||
| Q3 25 | -60.0% | -5.1% | ||
| Q2 25 | -34.7% | -32.7% | ||
| Q1 25 | -44.7% | -13.3% | ||
| Q4 24 | -52.8% | -25.0% | ||
| Q3 24 | 27.9% | -82.2% | ||
| Q2 24 | -41.3% | -76.5% | ||
| Q1 24 | -28.4% | 50.6% |
| Q4 25 | $-0.75 | $-0.17 | ||
| Q3 25 | $-0.94 | $-0.02 | ||
| Q2 25 | $-0.66 | $-0.11 | ||
| Q1 25 | $-0.67 | $-0.04 | ||
| Q4 24 | $-0.65 | $-0.02 | ||
| Q3 24 | $0.24 | $-0.21 | ||
| Q2 24 | $-0.42 | $-0.20 | ||
| Q1 24 | $-0.27 | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $169.6M | $36.8M |
| Total DebtLower is stronger | $428.4M | — |
| Stockholders' EquityBook value | $128.7M | $35.5M |
| Total Assets | $1.2B | $70.6M |
| Debt / EquityLower = less leverage | 3.33× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $169.6M | $36.8M | ||
| Q3 25 | $2.1M | $21.9M | ||
| Q2 25 | $4.2M | $18.7M | ||
| Q1 25 | $3.0M | $22.7M | ||
| Q4 24 | $115.2M | $26.6M | ||
| Q3 24 | $155.1M | $40.3M | ||
| Q2 24 | $116.0M | $43.1M | ||
| Q1 24 | $92.3M | $51.2M |
| Q4 25 | $428.4M | — | ||
| Q3 25 | $415.9M | $19.4M | ||
| Q2 25 | $338.6M | $19.4M | ||
| Q1 25 | $336.5M | $19.4M | ||
| Q4 24 | $373.8M | $19.3M | ||
| Q3 24 | $122.5M | $32.1M | ||
| Q2 24 | $119.7M | $31.8M | ||
| Q1 24 | $120.2M | $31.3M |
| Q4 25 | $128.7M | $35.5M | ||
| Q3 25 | $131.7M | $-4.5M | ||
| Q2 25 | $135.3M | $-7.5M | ||
| Q1 25 | $137.1M | $-5.9M | ||
| Q4 24 | $139.1M | $-5.9M | ||
| Q3 24 | $142.9M | $-5.2M | ||
| Q2 24 | $142.5M | $-1.4M | ||
| Q1 24 | $144.5M | $3.0M |
| Q4 25 | $1.2B | $70.6M | ||
| Q3 25 | $222.1M | $49.3M | ||
| Q2 25 | $220.3M | $44.9M | ||
| Q1 25 | $186.2M | $46.4M | ||
| Q4 24 | $967.0M | $44.9M | ||
| Q3 24 | $800.8M | $58.9M | ||
| Q2 24 | $756.2M | $63.2M | ||
| Q1 24 | $727.4M | $69.2M |
| Q4 25 | 3.33× | — | ||
| Q3 25 | 3.16× | — | ||
| Q2 25 | 2.50× | — | ||
| Q1 25 | 2.45× | — | ||
| Q4 24 | 2.69× | — | ||
| Q3 24 | 0.86× | — | ||
| Q2 24 | 0.84× | — | ||
| Q1 24 | 0.83× | 10.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $27.8M | $-6.0M |
| Free Cash FlowOCF − Capex | $10.4M | — |
| FCF MarginFCF / Revenue | 55.0% | — |
| Capex IntensityCapex / Revenue | 91.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $25.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.8M | $-6.0M | ||
| Q3 25 | $13.4M | $1.5M | ||
| Q2 25 | $13.9M | $-3.7M | ||
| Q1 25 | $951.0K | $-4.3M | ||
| Q4 24 | $9.1M | $-1.5M | ||
| Q3 24 | $1.7M | $-2.2M | ||
| Q2 24 | $1.3M | $-8.4M | ||
| Q1 24 | $1.1M | $39.0M |
| Q4 25 | $10.4M | — | ||
| Q3 25 | $8.7M | — | ||
| Q2 25 | $8.8M | — | ||
| Q1 25 | $-2.9M | — | ||
| Q4 24 | $-253.0K | — | ||
| Q3 24 | $-601.0K | — | ||
| Q2 24 | $-654.0K | — | ||
| Q1 24 | $-630.0K | — |
| Q4 25 | 55.0% | — | ||
| Q3 25 | 52.4% | — | ||
| Q2 25 | 52.2% | — | ||
| Q1 25 | -17.6% | — | ||
| Q4 24 | -1.8% | — | ||
| Q3 24 | -4.7% | — | ||
| Q2 24 | -5.2% | — | ||
| Q1 24 | -5.6% | — |
| Q4 25 | 91.8% | — | ||
| Q3 25 | 28.5% | — | ||
| Q2 25 | 30.3% | — | ||
| Q1 25 | 23.4% | — | ||
| Q4 24 | 66.9% | — | ||
| Q3 24 | 18.0% | — | ||
| Q2 24 | 15.3% | — | ||
| Q1 24 | 15.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BHM
| Residential Communities Segment | $11.4M | 61% |
| Scattered Single Family Homes Segment | $7.5M | 39% |
FENC
Segment breakdown not available.
